BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tamminga M, Hiltermann TJN, Schuuring E, Timens W, Fehrmann RS, Groen HJ. Immune microenvironment composition in non-small cell lung cancer and its association with survival. Clin Transl Immunology 2020;9:e1142. [PMID: 32547744 DOI: 10.1002/cti2.1142] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Lu Y, Luo X, Wang Q, Chen J, Zhang X, Li Y, Chen Y, Li X, Han S. A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma. Front Genet 2022;13:862741. [DOI: 10.3389/fgene.2022.862741] [Reference Citation Analysis]
2 Ping S, Wang S, He J, Chen J. Identification and Validation of Immune-Related lncRNA Signature as a Prognostic Model for Skin Cutaneous Melanoma. Pharmgenomics Pers Med 2021;14:667-81. [PMID: 34113151 DOI: 10.2147/PGPM.S310299] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Lin Z, Pang K, Li H, Zhang X, Wan J, Zheng T, Liu T, Peng W. Characterization of Immune-Related Long Non-coding RNAs to Construct a Novel Signature and Predict the Prognosis and Immune Landscape of Soft Tissue Sarcoma. Front Cell Dev Biol 2021;9:709241. [PMID: 34631703 DOI: 10.3389/fcell.2021.709241] [Reference Citation Analysis]
4 Li X, Zhou L, Lu T, Zhang L, Li Y, Xu J, Yin M, Long H. Constructing an immune- and ferroptosis-related lncRNA signature to predict the immune landscape of human bladder cancer. J Clin Lab Anal 2022;:e24389. [PMID: 35421267 DOI: 10.1002/jcla.24389] [Reference Citation Analysis]
5 Liang M, Gong D, Wang L, Liang X, Meng J, Huang W, Zhou J. PAX5 haploinsufficiency induced CD8+ T cells dysfunction or exhaustion by high expression of immune inhibitory-related molecules. Cancer Treat Res Commun 2021;28:100437. [PMID: 34425470 DOI: 10.1016/j.ctarc.2021.100437] [Reference Citation Analysis]
6 Han Y, Ding Z, Chen B, Liu Y, Liu Y. A Novel Inflammatory Response–Related Gene Signature Improves High-Risk Survival Prediction in Patients With Head and Neck Squamous Cell Carcinoma. Front Genet 2022;13:767166. [DOI: 10.3389/fgene.2022.767166] [Reference Citation Analysis]
7 Li R, Lin Y, Wang Y, Wang S, Yang Y, Mu X, Chen Y, Gao Z. Characterization of the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma Using Imaging Mass Cytometry. Front Oncol 2021;11:620989. [PMID: 33869005 DOI: 10.3389/fonc.2021.620989] [Reference Citation Analysis]
8 Wang X, Chen K, Wang Z, Xu Y, Dai L, Bai T, Chen B, Yang W, Chen W. Using Immune-Related Long Non-coding Ribonucleic Acids to Develop a Novel Prognosis Signature and Predict the Immune Landscape of Colon Cancer. Front Cell Dev Biol 2021;9:750709. [PMID: 34660608 DOI: 10.3389/fcell.2021.750709] [Reference Citation Analysis]
9 Li M, Wang H, Li W, Peng Y, Xu F, Shang J, Dong S, Bu L, Wang H, Wei W, Hu Q, Liu L, Zhao Q. Identification and validation of an immune prognostic signature in colorectal cancer. Int Immunopharmacol 2020;88:106868. [PMID: 32771948 DOI: 10.1016/j.intimp.2020.106868] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
10 Liu S, Peng X, Wu X, Bu F, Yu Z, Zhu J, Luo C, Zhang W, Liu J, Huang J. Construction of a new immune-related lncRNA model and prediction of treatment and survival prognosis of human colon cancer. World J Surg Onc 2022;20. [DOI: 10.1186/s12957-022-02508-2] [Reference Citation Analysis]
11 Hong W, Liang L, Gu Y, Qi Z, Qiu H, Yang X, Zeng W, Ma L, Xie J. Immune-Related lncRNA to Construct Novel Signature and Predict the Immune Landscape of Human Hepatocellular Carcinoma. Mol Ther Nucleic Acids 2020;22:937-47. [PMID: 33251044 DOI: 10.1016/j.omtn.2020.10.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 25] [Article Influence: 8.5] [Reference Citation Analysis]
12 Zhai Y, Zhao B, Wang Y, Li L, Li J, Li X, Chang L, Chen Q, Liao Z. Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinoma. BMC Cancer 2021;21:213. [PMID: 33648465 DOI: 10.1186/s12885-021-07911-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Monastirioti A, Papadaki C, Rounis K, Kalapanida D, Mavroudis D, Agelaki S. A Prognostic Role for Circulating microRNAs Involved in Macrophage Polarization in Advanced Non-Small Cell Lung Cancer. Cells 2021;10:1988. [PMID: 34440757 DOI: 10.3390/cells10081988] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Gao L, Xue J, Liu X, Cao L, Wang R, Lei L. A risk model based on autophagy-related lncRNAs for predicting prognosis and efficacy of immunotherapy and chemotherapy in gastric cancer patients. Aging (Albany NY) 2021;13:25453-65. [PMID: 34897033 DOI: 10.18632/aging.203765] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Ding Z, Shen H, Xu K, Wu Y, Wang S, Yi F, Wang D, Liu Y. Comprehensive Analysis of mTORC1 Signaling Pathway–Related Genes in the Prognosis of HNSCC and the Response to Chemotherapy and Immunotherapy. Front Mol Biosci 2022;9:792482. [DOI: 10.3389/fmolb.2022.792482] [Reference Citation Analysis]
16 Chengcheng L, Wenwen Q, Ningyue G, Fangyuan Z, Runtong X, Zhenxiao T, Fenglei X, Yiming Q, Miaoqing Z, Xiaoming L, Ming X. Identification of the Immune-Related Genes in Tumor Microenvironment That Associated With the Recurrence of Head and Neck Squamous Cell Carcinoma. Front Cell Dev Biol 2021;9:723721. [PMID: 34490269 DOI: 10.3389/fcell.2021.723721] [Reference Citation Analysis]
17 Wang M, Zhu J, Zhao F, Xiao J. Transcriptome Analyses Identify a Metabolic Gene Signature Indicative of Antitumor Immunosuppression of EGFR Wild Type Lung Cancers With Low PD-L1 Expression. Front Oncol 2021;11:643503. [PMID: 34595103 DOI: 10.3389/fonc.2021.643503] [Reference Citation Analysis]
18 Jiang H, Xu A, Li M, Han R, Wang E, Wu D, Fei G, Zhou S, Wang R. Seven autophagy-related lncRNAs are associated with the tumor immune microenvironment in predicting survival risk of nonsmall cell lung cancer. Brief Funct Genomics 2021:elab043. [PMID: 34849558 DOI: 10.1093/bfgp/elab043] [Reference Citation Analysis]
19 Luan JC, Zeng TY, Zhang QJ, Xia DR, Cong R, Yao LY, Song LB, Zhou X, Zhou X, Chen X, Xia JD, Song NH. A novel signature constructed by ferroptosis-associated genes (FAGs) for the prediction of prognosis in bladder urothelial carcinoma (BLCA) and associated with immune infiltration. Cancer Cell Int 2021;21:414. [PMID: 34362387 DOI: 10.1186/s12935-021-02096-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Hua S, Xie Z, Wang W, Wan Z, Chen M, Zhao S, Jiang J. Identification and Validation of a Novel Immune-Related lncRNA Signature for Bladder Cancer. Front Oncol 2021;11:704946. [PMID: 34322391 DOI: 10.3389/fonc.2021.704946] [Reference Citation Analysis]
21 Sun S, Du W, Sun Q, Zhao X, Qin B, Shi D, Wan C, Wu Z. Driver gene alterations profiling of Chinese non-small cell lung cancer and the effects of co-occurring alterations on immunotherapy. Cancer Med 2021;10:7360-72. [PMID: 34599863 DOI: 10.1002/cam4.4178] [Reference Citation Analysis]
22 Shen S, Chen X, Hu X, Huo J, Luo L, Zhou X. Predicting the immune landscape of invasive breast carcinoma based on the novel signature of immune-related lncRNA. Cancer Med 2021. [PMID: 34378851 DOI: 10.1002/cam4.4189] [Reference Citation Analysis]
23 Qi X, Chen G, Chen Z, Li J, Chen W, Lin J, Lin L. Construction of a Novel Lung Adenocarcinoma Immune-Related lncRNA Pair Signature. Int J Gen Med 2021;14:4279-89. [PMID: 34421308 DOI: 10.2147/IJGM.S325240] [Reference Citation Analysis]
24 Chen S, Ma S, Yan J, Wang H, Ding B, Guo Z, Ma Y, Chen X, Wang Y. Pan-Cancer Analyses Reveal Oncogenic Role and Prognostic Value of F-Box Only Protein 22. Front Oncol 2022;11:790912. [DOI: 10.3389/fonc.2021.790912] [Reference Citation Analysis]
25 Anderson R, Blidner AG, Rapoport BL. Frontiers in Pharmacology: Review Manuscript Targeting of the Neutrophil as an Adjunctive Strategy in Non-Small Cell Lung Cancer. Front Pharmacol 2021;12:676399. [PMID: 34168563 DOI: 10.3389/fphar.2021.676399] [Reference Citation Analysis]
26 Eftimie R, Barelle C. Mathematical investigation of innate immune responses to lung cancer: The role of macrophages with mixed phenotypes. J Theor Biol 2021;524:110739. [PMID: 33930438 DOI: 10.1016/j.jtbi.2021.110739] [Reference Citation Analysis]
27 Li H, Wang J, Zhang L. Construction of a circRNA-Related Prognostic Risk Score Model for Predicting the Immune Landscape of Lung Adenocarcinoma. Front Genet 2021;12:668311. [PMID: 34434213 DOI: 10.3389/fgene.2021.668311] [Reference Citation Analysis]
28 Fan T, Li C, He J. Prognostic value of immune-related genes and comparative analysis of immune cell infiltration in lung adenocarcinoma: sex differences. Biol Sex Differ 2021;12:64. [PMID: 34863300 DOI: 10.1186/s13293-021-00406-y] [Reference Citation Analysis]
29 Zhao F, Wang M, Zhu J. Hypoxia-related lncRNAs to build prognostic classifier and reveal the immune characteristics of EGFR wild type and low expression of PD-L1 squamous and adenocarcinoma NSCLC. Cancer Med 2021. [PMID: 34250747 DOI: 10.1002/cam4.4126] [Reference Citation Analysis]
30 Yin W, Lv J, Yao Y, Zhao Y, He Z, Wang Q, Cui L, Dai H. Elevations of monocyte and neutrophils, and higher levels of granulocyte colony-stimulating factor in peripheral blood in lung cancer patients. Thorac Cancer 2021;12:2680-90. [PMID: 34498383 DOI: 10.1111/1759-7714.14103] [Cited by in F6Publishing: 1] [Reference Citation Analysis]